FIELD: medicine.
SUBSTANCE: composition is based on gadolinium (Gd3+) complex aqueous solutions comprising gadolinium (Gd3+) complex with disodium salt of diethylenetriaminopentacetic acid or of dimethylamide diethylenetriaminopentacetic acid and additional metal-to-chrome indicator having stability constant of 12-16 units at pH equal to 6-8 in concentration of 0.0001-0.5% by gadolinium mass.
EFFECT: increased diagnostic data volume; simplified quality control; improved falsification protection.
2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| CONTRAST GADOLINIUM COMPLEX COMPOSITION FOR MEDICAL DIAGNOSTICS | 2009 |
|
RU2396983C1 |
| PREPARATION FOR APPLICATION IN PHOTON CAPTURE THERAPY OF MALIGNANT SOLID NEOPLASMS | 2015 |
|
RU2611379C1 |
| GADOPENTETATE-MODIFIED BETA-CYCLODEXTRIN DERIVATIVES | 2013 |
|
RU2541090C1 |
| MEGNETIC-RESONANCE OPAQUE COMPOSITION | 1998 |
|
RU2150961C1 |
| MEDICINAL CONTRAST COMPOSITION | 2016 |
|
RU2639390C2 |
| CONTRAST COMPOSITION FOR MAGNETIC RESONANCE IMAGING AND ANGIOGRAPHY BASED ON Mn-DCTA | 2020 |
|
RU2776412C2 |
| HEPATO-TROPIC MAGNETIC RESONANCE DEVICE | 2014 |
|
RU2577298C1 |
| HEPATOTROPHIC MAGNETIC RESONANCE CONTRAST MEDIUM BASED ON GADOLINIUM CHELATE COMPLEX | 2016 |
|
RU2663469C2 |
| MAGNETIC RESONANT AND RADIOPAQUE CONTRAST AGENT BASED ON COMPLEX FERRIC OXIDE AND METHOD FOR PRODUCING THEREOF | 2009 |
|
RU2419454C1 |
| COMPOSITION OF CONTRAST AGENTS AND METHOD OF ITS OBTAINING | 2019 |
|
RU2815053C2 |
